A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC
Clinical trial NCT06793761 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06793761
- Sponsor
- Beijing Tongren Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-12-20
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.